Literature DB >> 18950867

Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice.

Tanja Scheikl1, Bernhard Reis, Klaus Pfeffer, Bernhard Holzmann, Sandra Beer.   

Abstract

MZ B cells represent a distinct lineage of naive B lymphocytes, apart from FO B cells and peritoneal B1 cells, and mediate humoral immune responses against blood-borne type 2 T-independent antigens. Regulation of MZ B cell development involves the Notch receptor signaling, the intensity of B cell receptor signals, and cell compartmentalization by adhesion and chemokine receptors. Our previous work showed that gene-targeted mice expressing a truncated form of the putative signaling adapter protein SLy1 exhibit reduced numbers of a splenic B cell population enriched in MZ B cells. Here, we demonstrate that Sly1(d/d) mice exhibit a partial, but selective, block in the transition from pre-MZ to mature MZ B cells. Development of both T1 and T2 precursor subsets and FO B cells was normal in Sly1(d/d) mice. Consistent with the loss of MZ B cells, the production of antigen-specific IgM antibodies following immunization with pneumococcal polysaccharides was severely impaired in Sly1(d/d) mice. Importantly, expression of the Notch signaling mediator RBP-J and the Notch target genes Hes-1 and Hes-5 was markedly reduced in MZ but not FO B cells of Sly1(d/d) mice. In contrast, B cell receptor signaling, expression and function of LFA-1 and alpha4-integrins, and expression of chemokine receptors appeared intact in Sly1(d/d) cells. Collectively, these results provide strong evidence that SLy1 is important for the generation and function of MZ B cells and suggest a novel link between SLy1 and the activity of the Notch pathway in the development of MZ B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950867     DOI: 10.1016/j.molimm.2008.09.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells.

Authors:  Elizabeth M Samuelson; Renee M Laird; Alexander C Maue; Rosemary Rochford; Sandra M Hayes
Journal:  Immunol Cell Biol       Date:  2011-09-06       Impact factor: 5.126

2.  Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.

Authors:  Melody Sauerborn; Miranda M C van Beers; Wim Jiskoot; Grzegorz M Kijanka; Louis Boon; Huub Schellekens; Vera Brinks
Journal:  J Clin Immunol       Date:  2012-09-04       Impact factor: 8.317

3.  SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.

Authors:  Ottavia M Delmonte; Jenna R E Bergerson; Tomoki Kawai; Hye Sun Kuehn; David H McDermott; Irene Cortese; Michael T Zimmermann; A Kerry Dobbs; Marita Bosticardo; Danielle Fink; Shamik Majumdar; Boaz Palterer; Francesca Pala; Nikita R Dsouza; Marie Pouzolles; Naomi Taylor; Katherine R Calvo; Stephen R Daley; Daniel Velez; Anahita Agharahimi; Katherine Myint-Hpu; Lesia K Dropulic; Jonathan J Lyons; Steven M Holland; Alexandra F Freeman; Rajarshi Ghosh; Morgan B Similuk; Julie E Niemela; Jennifer Stoddard; Douglas B Kuhns; Raul Urrutia; Sergio D Rosenzweig; Magdalena A Walkiewicz; Philip M Murphy; Luigi D Notarangelo
Journal:  Blood       Date:  2021-09-23       Impact factor: 25.476

4.  A novel myeloid cell in murine spleen defined through gene profiling.

Authors:  Ying-Ying Hey; Terence J O'Neill; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2019-06-18       Impact factor: 5.310

5.  The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development.

Authors:  Bernhard Reis; Klaus Pfeffer; Sandra Beer-Hammer
Journal:  BMC Immunol       Date:  2009-07-15       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.